Sylentis
Agent43Agent Readiness: 43/100. Above median. Measured by StartupHub.ai. Median 41.Trust80Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.
About
Sylentis is a biopharmaceutical company specializing in ocular gene silencing therapies using RNA interference (RNAi) technology. They develop siRNA compounds to reduce the production of disease-causing proteins, with a current focus on treating dry eye syndrome and age-related macular degeneration. Sylentis also offers siRNA development services and collaborates with other companies on oligonucleotide-based drug development.
Similar companies
A biotechnology company developing genetic therapies for rare disorders.
Shares Drug Discovery, Clinical Trials
A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Shares Biotech, MedTech
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Shares Biotech, MedTech
Key facts
- Website
- sylentis.com
- Headquarters
- Madrid, Spain
- Founded
- 2000
- Employees
- 61
- Total funding
- $135M (Series C)
- Business model
- B2B
Funding rounds
Tech stack
Detected on sylentis.com, last scanned 3 Nov 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- CMS / Builders
- WordPress
- Email provider
- Barracuda
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Sylentis trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Sylentis is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Sylentis raised?
Sylentis has raised a total of $135M in funding. The most recent round on record is Series C.
How many employees does Sylentis have?
Sylentis has approximately 61 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Sylentis:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
